Chen MW - Search Results

1

Upregulation of POC1A in lung adenocarcinoma promotes tumour progression and predicts poor prognosis.

Li ZH, Li JY, Wu ZT, Zhu YJ, Zhuo T, Nong JS, Qian J, Peng HJ, Dai L, Wang YY, Chen MW, Zeng XC. Li ZH, et al. Among authors: chen mw. J Cell Mol Med. 2024 Mar;28(6):e18135. doi: 10.1111/jcmm.18135. J Cell Mol Med. 2024. PMID: 38429900 Free PMC article.

2

Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapy.

Leng XF, Chen MW, Xian L, Dai L, Ma GY, Li MH. Leng XF, et al. Among authors: chen mw. J Exp Clin Cancer Res. 2012 Mar 23;31(1):25. doi: 10.1186/1756-9966-31-25. J Exp Clin Cancer Res. 2012. PMID: 22439756 Free PMC article.

3

[Screening key genes associated with the development and progression of non-small cell lung cancer based on gene-enrichment analysis and meta-analysis].

He W, Xian L, Wang Y, Hu Y, Chen M. He W, et al. Zhongguo Fei Ai Za Zhi. 2012 Jul;15(7):416-21. doi: 10.3779/j.issn.1009-3419.2012.07.05. Zhongguo Fei Ai Za Zhi. 2012. PMID: 22814261 Free PMC article. Chinese.

4

Genetic polymorphism of MTHFR A1298C and esophageal cancer susceptibility: a meta-analysis.

Tan X, Wang YY, Dai L, Liao XQ, Chen MW. Tan X, et al. Among authors: chen mw. Asian Pac J Cancer Prev. 2013;14(3):1951-5. doi: 10.7314/apjcp.2013.14.3.1951. Asian Pac J Cancer Prev. 2013. PMID: 23679298 Free article.

5

Polymorphism of ERCC2 Asp312Asn with lung cancer risk: evidence from 20,101 subjects.

Tan X, Wang Y, Shi L, Xian L, Guo J, Liang G, Chen M. Tan X, et al. Genet Test Mol Biomarkers. 2014 Jan;18(1):50-6. doi: 10.1089/gtmb.2013.0296. Epub 2013 Oct 1. Genet Test Mol Biomarkers. 2014. PMID: 24083550

6

Association between ERCC2 Lys751Gln polymorphism and lung cancer risk: a meta-analysis involving 23,370 subjects.

Tan X, Xian L, Chen X, Shi L, Wang Y, Guo J, Liang G, Zhao Z, Chen M. Tan X, et al. Twin Res Hum Genet. 2014 Apr;17(2):99-107. doi: 10.1017/thg.2014.4. Epub 2014 Feb 20. Twin Res Hum Genet. 2014. PMID: 24556168

7

Responses to crizotinib and disease monitoring with circulating tumor cells in lung adenocarcinoma patient with MET exon 14 skipping mutation: A case report.

Tan X, Dai L, Wang Y, Liang G, Yang N, Chen M. Tan X, et al. Medicine (Baltimore). 2017 Nov;96(47):e8744. doi: 10.1097/MD.0000000000008744. Medicine (Baltimore). 2017. PMID: 29381967 Free PMC article.

8

Effect of Osimertinib on the expression of serum mmp-7 and mmp-9 in patients with non-small cell lung cancer.

Yang N, Wan R, Dai L, Wang Y, Tan X, Chen M, Guo J, Zhou H. Yang N, et al. Pak J Pharm Sci. 2020 Jan;33(1(Special)):499-504. Pak J Pharm Sci. 2020. PMID: 32173649

9

Clinical Significance of Red Cell Distribution Width and Circulating Tumor Cells with an Epithelial-Mesenchymal Transition Phenotype in Lung Adenocarcinoma.

Peng H, Tan X, Wang Y, Dai L, Liang G, Guo J, Chen M. Peng H, et al. Cancer Manag Res. 2020 Jun 26;12:5105-5117. doi: 10.2147/CMAR.S251271. eCollection 2020. Cancer Manag Res. 2020. PMID: 32636675 Free PMC article.

10

Clinical significance of Ki67 and circulating tumor cells with an epithelial-mesenchymal transition phenotype in non-small cell lung cancer.

Peng H, Tan X, Wang Y, Dai L, Liang G, Guo J, Chen M. Peng H, et al. Am J Transl Res. 2020 Jun 15;12(6):2916-2928. eCollection 2020. Am J Transl Res. 2020. PMID: 32655819 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

407 results

Search Page

Filters